Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$164.52 - $238.84 $2,467 - $3,582
15 New
15 $3.55 Million
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $4,490 - $6,652
-22 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $5,621 - $7,966
22 New
22 $6.25 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.84B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Laffer Tengler Investments Portfolio

Follow Laffer Tengler Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laffer Tengler Investments, based on Form 13F filings with the SEC.

News

Stay updated on Laffer Tengler Investments with notifications on news.